OrphoMed's Convertible Note Round

OrphoMed raised a round of funding on August 13, 2015.

OrphoMed is a San Francisco Bay Area pharmaceutical company focused on drugs based on the DIMERx dimer technology platform. Components of the dimers have previously been proven to be safe and effectiv…

Articles about OrphoMed's Convertible Note Round: